ATE425754T1 - Bezdioxan-piperazin-derivate mit einer kombination aus affinitat fur dopamin-d2- rezeptoren und serotonin-wiederaufnahme-stellen - Google Patents

Bezdioxan-piperazin-derivate mit einer kombination aus affinitat fur dopamin-d2- rezeptoren und serotonin-wiederaufnahme-stellen

Info

Publication number
ATE425754T1
ATE425754T1 AT05817508T AT05817508T ATE425754T1 AT E425754 T1 ATE425754 T1 AT E425754T1 AT 05817508 T AT05817508 T AT 05817508T AT 05817508 T AT05817508 T AT 05817508T AT E425754 T1 ATE425754 T1 AT E425754T1
Authority
AT
Austria
Prior art keywords
bezdioxan
dopamine
receptors
affinity
combination
Prior art date
Application number
AT05817508T
Other languages
English (en)
Inventor
Hes Roelof Van
Pieter Smid
Cornelis G Kruse
Martinus T M Tulp
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Application granted granted Critical
Publication of ATE425754T1 publication Critical patent/ATE425754T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT05817508T 2004-12-07 2005-12-06 Bezdioxan-piperazin-derivate mit einer kombination aus affinitat fur dopamin-d2- rezeptoren und serotonin-wiederaufnahme-stellen ATE425754T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63344704P 2004-12-07 2004-12-07
EP04106361 2004-12-07

Publications (1)

Publication Number Publication Date
ATE425754T1 true ATE425754T1 (de) 2009-04-15

Family

ID=34930008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05817508T ATE425754T1 (de) 2004-12-07 2005-12-06 Bezdioxan-piperazin-derivate mit einer kombination aus affinitat fur dopamin-d2- rezeptoren und serotonin-wiederaufnahme-stellen

Country Status (15)

Country Link
EP (1) EP1824486B1 (de)
JP (1) JP2008523028A (de)
KR (1) KR20070087644A (de)
CN (1) CN101072563A (de)
AR (1) AR052332A1 (de)
AT (1) ATE425754T1 (de)
AU (1) AU2005313388A1 (de)
BR (1) BRPI0518372A2 (de)
CA (1) CA2587940A1 (de)
MX (1) MX2007006758A (de)
RU (1) RU2007125691A (de)
SA (1) SA05260390B1 (de)
TW (1) TW200631952A (de)
WO (1) WO2006061374A1 (de)
ZA (1) ZA200704156B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8063062B2 (en) 2006-12-20 2011-11-22 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition
US8138174B2 (en) 2007-01-10 2012-03-20 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition
EP2111394A1 (de) * 2007-01-10 2009-10-28 Solvay Pharmaceuticals B.V. Verbindungen mit einer kombination aus cannabinoid-cb1-antagonismus und serotonin-wiederaufnahmehemmung
KR101387970B1 (ko) 2011-04-20 2014-04-25 인제대학교 산학협력단 암 예방 및 치료용 조성물 및 건강기능식품
US9598401B2 (en) 2013-07-29 2017-03-21 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof
CN110041318B (zh) * 2018-01-17 2022-07-29 中国科学院上海药物研究所 一类多巴胺d5受体激动剂及其制备和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
WO1999005140A1 (en) * 1997-07-25 1999-02-04 H. Lundbeck A/S Indole and 2,3-dihydroindole derivatives, their preparation and use
SK287018B6 (sk) * 1999-08-23 2009-09-07 Solvay Pharmaceuticals B. V. Deriváty fenylpiperazínov, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitie
DE10259244A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh N-(Indolethyl-)cycloamin-Verbindungen

Also Published As

Publication number Publication date
JP2008523028A (ja) 2008-07-03
SA05260390B1 (ar) 2009-04-01
RU2007125691A (ru) 2009-01-20
MX2007006758A (es) 2007-11-09
CA2587940A1 (en) 2006-06-15
AR052332A1 (es) 2007-03-14
EP1824486B1 (de) 2009-03-18
ZA200704156B (en) 2008-05-28
BRPI0518372A2 (pt) 2008-11-18
KR20070087644A (ko) 2007-08-28
EP1824486A1 (de) 2007-08-29
AU2005313388A1 (en) 2006-06-15
CN101072563A (zh) 2007-11-14
TW200631952A (en) 2006-09-16
WO2006061374A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
ATE413874T1 (de) Neue thiophen-derivate als sphingosin-1-phosphat- 1-rezeptorantagonisten
ATE523195T1 (de) Neue thiophen-derivate als sphingosin-1-phosphat- 1-rezeptorantagonisten
IS8158A (is) Kínúklídínafleiður sem tengjast múskarín M3 viðtökum
MA28902B1 (fr) Agonistes des recepteurs beta2 adrenergiques diaminiques
ATE425754T1 (de) Bezdioxan-piperazin-derivate mit einer kombination aus affinitat fur dopamin-d2- rezeptoren und serotonin-wiederaufnahme-stellen
DE502004006697D1 (de) Spirocyclische cyclohexan-derivate mit affinität zum orl1-rezeptor
ATE448205T1 (de) Chinolin- und chinazolinderivate mit affinität für 5ht1-rezeptoren
CR10733A (es) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
DE602009000202D1 (de) Positive Resistzusammensetzung und Strukturierungsverfahren
ATE414088T1 (de) Polymorphe formen eines gabaa-agonisten
ATE531720T1 (de) Aza-benzofuranylverbindungen und anwendungsverfahren dafür
IL188758A0 (en) Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
DE602006003767D1 (de) Zylinderlaufbüchse und herstellungsverfahren dafür
CR10779A (es) Agonist trkb antibodies and uses thereof
DE602006012633D1 (de) Ausgleichsvorrichtung und Zylinderkopfanordnung
ATE555111T1 (de) Chinuclidinol-derivate als muscarinrezeptor- antagonisten
DE602006021136D1 (de) Hülse und zylinderkopfabdeckung
JP2008525358A5 (ja) Ｍ３ムスカリン受容体としてのピロリジニウム誘導体
BRPI0614592A2 (pt) camada para reduzir a resistência do ar de um objeto que se move para frente
DE602005013675D1 (de) Indol-2-carboxamidin-derivate als antagonisten der nmda-rezeptoren
DK1928821T3 (da) Carboxamidderivater som muscarinreceptorantagonister
BRPI0718436A2 (pt) Novos derivados de benzamida como antagonistas da bradicina
DE602007008831D1 (de) Cyclohexyl-sulfonamid-derivate mit h3-rezeptoraktivität
ATE462696T1 (de) Aminomethyl-2-imidazole mit affinität zu mit dem trace-amin assoziierten rezeptoren
ATE396992T1 (de) Salze eines chinuclidin-derivats als antagonisten des muscarin-m3-rezeptors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties